Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where er Alp is active.

Publication


Featured researches published by er Alp.


Renal Failure | 2014

Assessment of volume status and arterial stiffness in chronic kidney disease.

Hakan Akdam; Handan Öğünç; Alper Alp; Özgül Özbek; İmran Kurt Ömürlü; Yavuz Yenicerioglu; Harun Akar

Abstract Aim: There is limited information about arterial stiffness in chronic kidney disease (CKD) which is an independent risk factor for cardiovascular events. Pulse wave velocity (PWV), augmentation index (AIx) are using to determine arterial stiffness. We aimed to study PWV, AIx, volume status in patients with stage 3B-5 CKD and continuous ambulatory peritoneal dialysis (CAPD). Methods: Sixty-six stage 3B-5 CKD patients, 21 CAPD patients, 34 healthy controls were included. Pulse wave velocity, AIx, volume status was evaluated by Mobil-O-Graph®, and bioimpedance spectroscopy, respectively. Results: The Median PWV was 7.5 m/s in CKD, 6.2 m/s in CAPD, 5.9 m/s in healthy controls, and while PWV was found to have increased significantly in CKD patients (p = 0.002), the Alx values were similar in all groups. The median extracellular fluid excess was higher in both the CKD and, CAPD patients when compared with healthy controls (1.26 and 1.21 L, respectively). Overhydration was more prevalent in CKD and CAPD patients (p < 0.001). Age, central systolic blood pressure, body mass index, fat mass, overhydration, CKD, eGFR were the major determinants of PWV. Conclusion: Increased PWV was found in stage 3B-5 CKD patients. Overhydration may contribute this increment.


Hemodialysis International | 2015

The effects of single hemodialysis session on arterial stiffness in hemodialysis patients.

Handan Öğünç; Hakan Akdam; Alper Alp; Fatih Gencer; Harun Akar; Yavuz Yenicerioglu

Increased arterial stiffness in hemodialysis patients is a strong predictor of cardiovascular morbidity and mortality. Pulse wave velocity (PWV) and augmentation index (AIx), which are markers of arterial stiffness, were used to determine the severity of vascular damage noninvasively. This study aimed to investigate the effects of solute volume removal and hemodynamic changes on PWV and AIx of a single hemodialysis session. Thirty hemodialysis patients were enrolled in the study. Before initiation of hemodialysis, every 15 minutes during hemodialysis, and 30 minutes after the completion of the session, measurements of PWV and AIx@75 (normalized with heart rate 75 bpm) were obtained from each patient. Body composition was analyzed by bioimpedance spectroscopy device before and 30 minutes after completion of the hemodialysis session. During the hemodialysis, no significant change was observed in AIx@75. However, PWV decreased steadily during the session reaching statistically significant level at 135th minute (P = 0.026), with a maximal drop at 210th minute (P < 0.001). At 210th minute, decrease in PWV correlated positively with the decrease in central systolic blood pressure, central diastolic blood pressure, central pulse pressure, augmentation pressure, and AIx@75. Multiple regression analysis showed that decrease in PWV at 210th minute was associated with decrease in central systolic blood pressure and central pulse pressure. Ultrafiltration during hemodialysis had no significant effect on PWV and AIx@75. Delta urea correlated positively with delta PWV at 240th minute. A significant decrease in PWV was observed during hemodialysis and correlated with urea reduction; however, we were unable to document any effect of volume removal on arterial stiffness.


BANTAO Journal | 2015

Impact of Interdialytic Weight Gain (IDWG) on Nutritional Parameters, Cardiovascular Risk Factors and Quality of Life in Hemodialysis Patients

Aysegul Kahraman; Hakan Akdam; Alper Alp; Mustafa Ahmet Huyut; Çağdaş Akgüllü; Tuba Balaban; Fadime Dinleyen; Aynur Topcu; Husniye Gelmez; Nevin Atakan; Harun Akar; Yavuz Yenicerioglu

Abstract Introduction. The amount of interdialytic weight gain (IDWG) considering body weight is of great importance in hemodialysis patients. In general practice, patients are asked to get standard weight between two hemodialysis sessions. However, it should be individualized considering patient’s weight. We aimed to determine the association between the IDWG and the nutritional parameters, cardiovascular risk factors, and quality of life. Methods. Thrity-two patients receiving hemodialysis at least for one year were enrolled into the study. Patients were monitored for 12 consecutive hemodialysis sessions; and the arithmetic mean of IDWG was calculated. IDWG% was calculated in accordance with patients’ dry weight. Data of patients with IDWG<3% (Group I) and IDWG≥3 (Group II) were compared. Sociodemographic variables, laboratory, anthropometric measurements, blood pressure, left ventricular mass index, Subjective Global Assessment Scale and SF-36 Quality of Life Scale were applied to evaluate the patients. Results. 59.4% (n=19) and 40.6% (n=13) of patients were included in Group I and Group II, respectively. In Group II, albumin (p=0.02), potassium (p=0.02), phosphorus (p=0.04), nPCR (p=0.03), physical function (p=0.04), role limitations caused by physical problems (p=0.04), general health (p=0.03), physical quality of life (p=0.04) scores were significantly higher. A significant correlation was detected between IDWG and physical and mental quality of life, total score SF-36, albumin, total protein and the potassium values. Conclusions. Patients with an IDWG ≥ 3% have better nutritional parameters and quality of life scales. The limiting of IDWG to 1-2 kg, ingoring patient weight may give rise to malnutrition and a reduced quality of life.


American Journal of Cardiology | 2015

Vortex Keratopathy: Fabry Related or Amiodarone Induced?

Alper Alp; Hakan Akdam

The report entitled “PP-116 vortex keratopathy associated with long term use of amiadarone,” written by Altun et al and published in a recent issue of American Journal of Cardiology, was quite interesting. Here, we would like to emphasize some relevant points. Amiodarone is widely used for treatment of atrial fibrillation. It has varying side effects and vortex keratopathy is 1 of them. We would like to point out that the differential diagnosis for this clinical entity shouldalso includeFabrydisease (FD).FD is an X-linked inherited, rare, progressive, multisystem disorder of glycosphingolipid metabolism affecting multiple organs and causing varying degrees of dysfunction. Cornea verticillata (vortex keratopathy) is one of the pathognomonic features of the disease. Indistinguishable pattern of amiodarone-induced vortex keratopathy from FD related cornea verticillata may confuse the diagnosis if solely considered. It is also claimed that corneal opacities of FD usually do not affect vision. Because of the wide spectrum of the disease, patients with FD are generally diagnosed at late ages. Vortex keratopathy in a patient with potential Fabry-related chronic heart disease, using amiodarone, may obscure the diagnosis if we narrow the differential diagnosis. Beyond FD, drugs such as chloroquine, hydroxychloroquine, gentamicine, nonsteroidal anti-inflammatory drugs may also induce vortex keratopathy. Other possible causes for vortex keratopathy should be kept in mind at clinical practice.


Hemodialysis International | 2016

Acute kidney injury after near drowning: The way from the beach to hemodialysis

Alper Alp; Hakan Akdam; Ibrahim Meteoglu; Alparslan Ünsal; Harun Akar; Yavuz Yenicerioglu

Acute kidney injury (AKI) occurs in many different situations and may have a variable prognosis influenced by clinical setting, underlying cause, and comorbidity. This is important because of the high mortality and morbidity risk affecting many people around the world. Near‐drowning related AKI requiring hemodialysis is very seldom reported in literature. Although cardiovascular and respiratory disorders are more frequently seen after this entity, we aimed to emphasize this rare but dangerous complication in near‐drowning patients.


Nefrologia | 2014

Polyarteritis nodosa complicated by posterior reversible encephalopathy syndrome: a case report

Alper Alp; Hakan Akdam; Harun Akar; Kutsi Koseoglu; Ayca Ozkul; Ibrahim Meteoglu; Yavuz Yenicerioglu

Hypertension (HT) represents a major public health problem affecting many individuals worldwide. It is well known to be an important risk factor for the development of cerebrovascular and cardiovascular diseases. Classifying hypertension as ‘primary’ or ‘secondary’ depends on the underlying mechanism. In 5 to 10% of hypertensive patients, HT develops ‘secondary’ to a separate mechanism that has been encountered with increasing frequency in the tertiary refferral centers. The frequent causes of secondary hypertension include renal parenchymal disease, renal artery stenosis, primary hyperaldosteronism, phaeochromocytoma and Cushings syndrome. Polyarteritis nodosa (PAN) can involve any organ and in varying degrees. Here we present a young hypertensive patient diagnosed as PAN with the angiographic findings of multiple microaneurysms involving celiac, renal and superior mesenteric arteries and associated with a rarely seen neurological entity-PRES syndrome.


Renal Failure | 2013

Malnutrition due to bisphosphonate-related osteonecrosis of the jaw in a chronic dialysis patient: case report

Gulcan Coskun Akar; Candan Efeoglu; Alper Alp; Kutsi Koseoglu; Haluk Erol; Yavuz Yenicerioglu; Harun Akar

Abstract Adequate nutrition is imperative for a successful outcome in dialysis patients. Excellent oral hygiene and an efficient mastication can help to correct several metabolic and endocrine disturbances as well as delay initiation of dialysis in patients with chronic renal failure. However, concerns exist about the risk of malnutrition and protein depletion. On the other hand, intravenous bisphosphonates are the current standard of care for the treatment of hypercalcemia of malignancy and for the prevention of skeletal complications associated with bone metastases. Recently, retrospective case studies have reported an association between long-term bisphosphonate therapy and osteonecrosis of the jaws. This complication occurs either spontaneously or after minor dento-alveolar surgery including extraction of teeth. A malnourished dialysis patient who showed the typical clinical features of bisphosphonate-related osteonecrosis of the jaw (BRONJ) without any obvious radiological changes in his panoramic radiograph is reported. To minimize the risk of BRONJ, patients initiated on bisphosphonates should optimize routine dental care and have their baseline oral health evaluated by both clinical and radiographic examinations before initiation of bisphosphonate therapy.


Turkish Nephrology Dialysis Transplantation | 2017

A New Enemy of the Kidneys: Synthetic Cannabinoids

Alper Alp; Hakan Akdam; Ayşe Gül Örmeci; Ibrahim Meteoglu; Emel Ceylan; Alparslan Ünsal; Yavuz Yenicerioglu

1 Tepecik Education and Research Hospital, Department of Nephrology, İzmir, Turkey 2 Adnan Menderes University, Faculty of Medicine Hospital, Department of Nephrology, Aydın, Turkey 3 Adnan Menderes University, Faculty of Medicine Hospital, Department of Pathology, Aydın, Turkey 4 Adnan Menderes University, Faculty of Medicine Hospital, Department of Chest Diseases, Aydın, Turkey 5 Adnan Menderes University, Faculty of Medicine Hospital, Department of Radiology, Aydın, Turkey doi: 10.5262/tndt.2017.1001.20


Revista Da Associacao Medica Brasileira | 2017

Arterial stiffness and 25-hydroxyvitamin D levels in chronic kidney disease patients

Hakan Akdam; Alper Alp

OBJECTIVE Arterial stiffness refers to arterial wall rigidity, particularly developing in central vessels. Arterial stiffness increases in early stage chronic kidney disease (CKD), and it is a strong predictor of cardiovascular and all cause mortality. Vitamin D has beneficial effects on blood pressure, vascular endothelial function and arterial stiffness. 25-hydroxyvitamin D (25(OH)D) deficiency is quite common worldwide and in the CKD population. We aimed to evaluate the prevalence of 25(OH)D deficiency and its relation with arterial stiffness in CKD. METHOD Our study included 101 patients (51 male, 50 female), with stages 3B-5 CKD not on dialysis. A single-cuff arteriograph device (Mobil-O-Graph) was used to evaluate arterial stiffness parameters of pulse wave velocity (PWV) and augmentation index (Alx@75). The patients were divided into two groups: group I vitamin D non-deficient [25(OH)D > 15 ng/mL] and group II vitamin D deficient [25(OH)D ≤ 15 ng/mL]. RESULTS Overall, the mean 25(OH)D level was 14.1±7.9 ng/mL and 70 patients (69.4%) were vitamin D deficient. The mean Alx@75 value was significantly higher in group II (28.6±10.8% vs. 23.3±13.5%, p=0.038). PWV was higher in group II, but the difference was not significant. Group II exhibited significantly lower serum albumin (p<0.001), hemoglobin (p=0.005), calcium (p=0.041) and estimated glomerular filtration rate (eGFR) (p=0.041), but significantly higher 24-hour proteinuria (p=0.011) and more females (p=0.006). Vitamin D was negatively correlated with Alx@75 augmentation pressure, parathyroid hormone, proteinuria and body mass index, and positively correlated with albumin, hemoglobin, eGFR, calcium and transferrin. 25(OH)D was independently associated with Alx@75 (beta=-0.469, p=0.001) and albumin (beta=0.447, p=0.002). CONCLUSION In CKD patients 25(OH)D deficiency was common, particularly in females. Level of 25(OH)D was independently associated with Alx@75.


Revista Da Associacao Medica Brasileira | 2017

Synthetic cannabinoids in the kidneys

Alper Alp; Hakan Akdam; Banu Yılmaz Avcıoğlu; Sibel Ersan

Acute kidney injury is an important cause of mortality and morbidity today and can occur due to several reasons. As time, geographic regions, and living conditions change, various etiological agents arise with nephrotoxic effects. Awareness of such nephrotoxic effects has been raised with the increasing frequency of addictive substance use, especially among young people in society.

Collaboration


Dive into the er Alp's collaboration.

Top Co-Authors

Avatar

Hakan Akdam

Adnan Menderes University

View shared research outputs
Top Co-Authors

Avatar

Harun Akar

Adnan Menderes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ceren Günel

Adnan Menderes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Emel Ceylan

Adnan Menderes University

View shared research outputs
Researchain Logo
Decentralizing Knowledge